… -term safety and efficacy of azilsartan in young patients … tolerability in once-daily doses of
2.5–20 mg in patients weighing < 50 kg and 5–40 mg in those weighing ≥ 50 kg. Most patients (…

… the efficacy of single‐pill combination (SPC) antihypertensive drugs in patients with
uncontrolled essential … trials on the efficacy of single‐pill combination antihypertensive drugs in …

… to affect up to 30% of patients with essential hypertension [51] , … In conclusion, in patients
with mild-to-moderate, essential … at least equivalent to amlodipine/valsartan with regard to office …

… We enrolled initially diagnosed mild essential hypertensive patients (BP ranged from 140/90
to 159/99 mmHg) with age from 25 to 75 years from outpatients. Exclusion criteria were as …

… In a study comparing the efficacy and safety of olmesartan, losartan, and valsartan in patients
treated for essential HTN, Giles et al reported a discontinuation rate of 16.9%, 13.5%, and …

… , valsartan and irbesartan).[18] The purpose of the current study was to assess the efficacy
and safety of … 8-16 mg once daily in individuals with mild to moderate essential hypertension. …

… For essential hypertension patients, our study included two studies compared aliskiren with
placebo, ARBs and HCT in changes of some closely related outcome indicators [20, 24]. All …

… Ingino C et.al, evaluated the trial of efficacy and safety of telmisartan in the treatment of
patients with mild to moderate essential hypertension, either … Over 12 weeks, patients received …

… in patients with mild to moderate hepatic … and valsartan was slightly increased in patients
with mild hepatic impairment (by 1.5, 1.5, and 1.2 times, respectively). In patients with moderate …

… as a single agent to patients with mild to moderate primary hypertension [25]. Specifically,
293 patients with mild-to-moderate essential hypertension were randomly assigned to receive …